Studying cytochrome P450 kinetics in drug metabolism

被引:1
作者
Kramer, Melissa A. [1 ]
Tracy, Timothy S. [1 ]
机构
[1] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA
关键词
atypical; biphasic; cytochrome P450; hepatocytes; heterotropic activation kinetics; K-m; microsomes; sigmoidal; substrate inhibition; V-max;
D O I
10.1517/17425255.4.5.591
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Determination of cytochrome P450 enzyme-mediated kinetics in vitro can be useful for predicting drug dosing and clearance in humans. Expressed P450s, human liver microsomes, human hepatocytes (both fresh and cryopreserved), and human liver slices are used to estimate Km and V-max values for determination of intrinsic clearance of the drug for scale-up to predict in vivo clearance. Objective: To describe the advantages and disadvantages of the various in vitro systems used to estimate kinetic parameters for disposition of drugs and the various kinetic profiles that can be observed. Methods: A review of the literature was conducted to evaluate the utility of the various in vitro preparations, the methods for determining kinetic parameters and the types of kinetic profiles that may be observed. Results/conclusions: The choice of in vitro system for determining kinetic parameters will depend on the objective of the studies, as each system has advantages and disadvantages. Kinetic parameter determinations must be carefully assessed to assure that the correct kinetic model is applied and the most accurate kinetic parameters are determined.
引用
收藏
页码:591 / 603
页数:13
相关论文
共 74 条
[61]   Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives [J].
Shou, MG ;
Mei, Q ;
Ettore, MW ;
Dai, RK ;
Baillie, TA ;
Rushmore, TH .
BIOCHEMICAL JOURNAL, 1999, 340 :845-853
[62]  
Tang CY, 2000, DRUG METAB DISPOS, V28, P567
[63]   Effect of albumin on phenytoin and tolbutamide metabolism in human liver microsomes: An impact more than protein binding [J].
Tang, CY ;
Lin, Y ;
Rodrigues, AD ;
Lin, JUH .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) :648-654
[64]   Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus [J].
Tucker, GT ;
Houston, JB ;
Huang, SM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (01) :107-117
[65]  
VandenBranden M, 1998, DRUG METAB DISPOS, V26, P1063
[66]  
Venkatakrishnan K, 2000, J PHARMACOL EXP THER, V293, P343
[67]   Organ slices for the evaluation of human drug toxicity [J].
Vickers, AEM ;
Fisher, RL .
CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (01) :87-96
[68]   Effect of commonly used organic solvents on the kinetics of cytochrome P4502B6-and 2C8-dependent activity in human liver microsomes [J].
Vuppugalla, Ragini ;
Chang, Shu-Ying ;
Zhang, Hongjian ;
Marathe, Punit H. ;
Rodrigues, David A. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (11) :1990-1995
[69]   Primary hepatocyte culture in collagen gel mixture and collagen sandwich [J].
Wang, Ying-Jie ;
Liu, Hong-Ling ;
Guo, Hai-Tao ;
Wen, Hong-Wei ;
Liu, Jun .
WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (05) :699-702
[70]   Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2 [J].
Wilkening, S ;
Bader, A .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2003, 17 (04) :207-213